"UK Scientists Develop Groundbreaking Lung Cancer Vaccine Using DNA Technology"

Scientists in London and Oxford are developing a groundbreaking lung cancer vaccine, known as 'LungVax', which could prevent up to 90% of cases by training the immune system to recognize and attack early signs of the disease. The vaccine targets neoantigens on abnormal lung cells and has received funding for initial manufacturing and research. If successful, it will move into clinical trials and could offer a viable route to preventing some of the earliest stage cancers from emerging.